Codes / ICD10CM / B70.1

B70.1 Sparganosis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Sparganosis

Summary

Sparganosis is a parasitic infection caused by the larval stage of the tapeworm Spirometra species. The condition typically results from the ingestion of contaminated water or undercooked meat containing the parasite, or through direct contact with infected intermediate hosts. It can affect various tissues, including the subcutaneous tissues, eyes, and central nervous system, leading to a range of clinical manifestations depending on the site of infection.

Causes

The infection is caused by the plerocercoid larvae of Spirometra tapeworms, which are transmitted to humans through several routes. Common sources include consuming raw or undercooked meat from infected animals (e.g., frogs, snakes, or birds) or drinking water contaminated with copepods (small crustaceans) that harbor the larvae. Direct contact with infected tissues, such as applying poultices made from raw meat to the skin, can also lead to infection.

Risk Factors

  • Ingestion of raw or undercooked meat from potentially infected animals.
  • Consumption of untreated water from endemic areas.
  • Use of traditional remedies involving raw animal tissue on the skin.
  • Residence or travel in regions where Spirometra is endemic, particularly in Asia, Africa, and the Americas.

Symptoms

  • Subcutaneous nodules or swellings, often migratory and painful.
  • Eye involvement, including eyelid swelling, pain, or visual disturbances.
  • Neurological symptoms if the central nervous system is affected, such as headaches, seizures, or focal deficits.
  • Gastrointestinal discomfort, though less common.

Diagnosis

Diagnosis is typically based on clinical presentation, exposure history, and imaging studies (e.g., MRI or CT scans) to identify lesions. Serological tests may detect antibodies, but definitive confirmation often requires histopathological examination of excised tissue to identify the larval parasite. Imaging helps assess the extent of tissue involvement, especially in cases with neurological or ocular symptoms.

Treatment Options

Treatment primarily involves surgical removal of the larval parasite when feasible, particularly for accessible lesions. Antiparasitic medications, such as praziquantel or albendazole, may be used to target remaining larvae or in cases where surgery is not possible. Supportive care, including pain management and anti-inflammatory agents, is often necessary to address symptoms.

Prognosis and Follow-Up

Prognosis is generally favorable with early diagnosis and treatment, especially when the parasite is localized and surgically removable. Delayed or inadequate treatment can lead to complications, particularly with neurological or ocular involvement. Follow-up may include monitoring for recurrence or residual symptoms, especially if complete removal was not achieved.

Complications

  • Chronic tissue damage or scarring from persistent infection.
  • Vision loss or eye damage if the eye is involved.
  • Neurological deficits or seizures in cases of central nervous system infection.
  • Secondary bacterial infections at the site of lesions.

Lifestyle & Prevention

  • Avoid consuming raw or undercooked meat from wild animals.
  • Ensure water sources are treated or safe for consumption, especially in endemic areas.
  • Refrain from using traditional remedies involving raw animal tissue on the skin.
  • Practice good hygiene and avoid contact with potentially contaminated water or soil.

When to Seek Professional Help

Seek medical attention if you develop unexplained subcutaneous nodules, eye swelling, or neurological symptoms after potential exposure to Spirometra (e.g., travel to endemic regions or consumption of raw meat). Early evaluation is critical to prevent complications.

Tips for Medical Coders

When coding for sparganosis, use ICD-10-CM code B70.1. Ensure documentation supports the diagnosis, including clinical findings, exposure history, and any diagnostic tests (e.g., imaging or histopathology). Note the anatomical site of infection, as this may impact additional coding or clinical context. Avoid coding for unspecified locations unless no further detail is available.

Book a walkthrough

B70.1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.